{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:19:33Z","timestamp":1772896773493,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,13]]},"DOI":"10.7759\/cureus.17930","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T12:52:28Z","timestamp":1631537548000},"source":"Crossref","is-referenced-by-count":2,"title":["Occurrence of Post-Transplant Lymphoproliferative Disease in a Renal Transplant Patient"],"prefix":"10.7759","author":[{"given":"Sofiah","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahel","family":"Haji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanjali","family":"Pulipati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad A","family":"Wahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalyana","family":"Ramamurthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker RC","year":"1995","unstructured":"Walker RC, Marshall WF, Strickler JG, et al.. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis. 1995, 20:1346-53. 10.1093\/clinids\/20.5.1346","journal-title":"Clin Infect Dis"},{"key":"ref2","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study","volume":"94","author":"Curtis RE","year":"1999","unstructured":"Curtis RE, Travis LB, Rowlings PA, et al.. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999, 94:2208-16.","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16502","article-title":"OPTN\/SRTR 2019 Annual Data Report: Kidney","volume":"21 Suppl 2","author":"Hart A","year":"2021","unstructured":"Hart A, Lentine KL, Smith JM, et al.. OPTN\/SRTR 2019 Annual Data Report: Kidney. Am J Transplant. 2021, 21 Suppl 2:21-137. 10.1111\/ajt.16502","journal-title":"Am J Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz G","year":"1993","unstructured":"Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993, 342:1514. 10.1016\/S0140-6736(05)80084-4","journal-title":"Lancet"},{"key":"ref5","unstructured":"EBV+ PTLD (Post-Transplant Lymphoproliferative Disorder) | HCPs. (2021). Accessed. 1 July 2021: https:\/\/www.ebvptld.com."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-017-0087-0","article-title":"Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients","volume":"6","author":"Bishnoi R","year":"2017","unstructured":"Bishnoi R, Bajwa R, Franke AJ, et al.. Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients. Exp Hematol Oncol. 2017, 6:26. 10.1186\/s40164-017-0087-0","journal-title":"Exp Hematol Oncol"},{"key":"ref7","article-title":"Epidemiology, clinical manifestations, and diagnosis of post-transplant lymphoproliferative disorders","author":"Friedberg","year":"2021","unstructured":"Friedberg, JW, Aster JC. Epidemiology, clinical manifestations, and diagnosis of post-transplant lymphoproliferative disorders. UpToDate. Post TW (ed): UpToDate, Waltham; 2021."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.08.007","article-title":"Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment","volume":"369","author":"Petrara MR","year":"2015","unstructured":"Petrara MR, Giunco S, Serraino D, Dolcetti R, De Rossi A. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment. Cancer Lett. 2015, 369:37-44. 10.1016\/j.canlet.2015.08.007","journal-title":"Cancer Lett"},{"key":"ref9","unstructured":"Double-Hit Lymphoma - Lymphoma Research Foundation. (2021). Accessed. 30 July 2021: https:\/\/lymphoma.org\/aboutlymphoma\/nhl\/dhl\/."},{"key":"ref10","unstructured":"Post-transplant Lymphoproliferative Disorder (PTLD) | National Kidney Foundation. (2017). Accessed. 30 July 2021: https:\/\/www.kidney.org\/atoz\/content\/post-transplant-lymphoproliferative-disorder-ptld."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08160.x","article-title":"Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines","volume":"149","author":"Parker A","year":"2010","unstructured":"Parker A, Bowles K, Bradley JA, et al.. Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol. 2010, 149:693-705. 10.1111\/j.1365-2141.2010.08160.x","journal-title":"Br J Haematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(02)02754-9","article-title":"Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease","volume":"34","author":"Pham PT","year":"2002","unstructured":"Pham PT, Wilkinson AH, Gritsch HA, et al.. Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease. Transplant Proc. 2002, 34:1178-81. 10.1016\/s0041-1345(02)02754-9","journal-title":"Transplant Proc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/69245-occurrence-of-post-transplant-lymphoproliferative-disease-in-a-renal-transplant-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:05Z","timestamp":1707507245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/69245-occurrence-of-post-transplant-lymphoproliferative-disease-in-a-renal-transplant-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.17930","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,13]]}}}